- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The European Medicines Agency (EMA) has granted conditional marketing authorization for the Janssen COVID-19 vaccine. The EMA announced this today, with a spokesperson commenting: “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens…This is the first vaccine which can be used as a single dose.” According to the article, data from the clinical trials has shown a 67% efficacy rate. Further monitoring of the vaccine’s safety and efficacy will continue.
Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars
Additional data provided by
English
Japanese
